Oppenheimer (OPY) Stock Forecast, Price Target & Predictions
OPY Stock Forecast
Oppenheimer stock forecast is as follows: an average price target of $90.00 (represents a 46.41% upside from OPY’s last price of $61.47) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
OPY Price Target
The average price target for Oppenheimer (OPY) is $90.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $90.00 to $90.00. This represents a potential 46.41% upside from OPY's last price of $61.47.
OPY Analyst Ratings
According to 1 Wall Street analysts, Oppenheimer's rating consensus is 'Buy'. The analyst rating breakdown for OPY stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Oppenheimer Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 20, 2022 | - | Oppenheimer | $90.00 | $33.25 | 170.68% | 46.41% |
| May 19, 2022 | - | Oppenheimer | $50.00 | $32.89 | 52.02% | -18.66% |
| May 16, 2022 | - | Oppenheimer | $22.00 | $32.21 | -31.70% | -64.21% |
| May 12, 2022 | - | Oppenheimer | $87.00 | $32.02 | 171.71% | 41.53% |
| May 12, 2022 | - | Oppenheimer | $19.00 | $32.09 | -40.79% | -69.09% |
| May 11, 2022 | - | Oppenheimer | $30.00 | $32.59 | -7.95% | -51.20% |
| May 11, 2022 | - | Oppenheimer | $60.00 | $32.59 | 84.11% | -2.39% |
| May 11, 2022 | - | Oppenheimer | $18.00 | $31.46 | -42.78% | -70.72% |
| May 09, 2022 | - | Oppenheimer | $24.00 | $32.04 | -25.10% | -60.96% |
| May 09, 2022 | - | Oppenheimer | $64.00 | $31.93 | 100.45% | 4.12% |
The latest Oppenheimer stock forecast, released on May 20, 2022 by Oppenheimer company, set a price target of $90.00, which represents a 170.68% increase from the stock price at the time of the forecast ($33.25), and a 46.41% increase from OPY last price ($61.47).
Oppenheimer Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $61.47 | $61.47 | $61.47 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Oppenheimer stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Oppenheimer's last price of $61.47. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 09, 2022 | Oppenheimer | Outperform | Outperform | Hold |
Oppenheimer's last stock rating was published by Oppenheimer on May 09, 2022. The company gave OPY a "Outperform" rating, the same as its previous rate.
Oppenheimer Financial Forecast
Oppenheimer Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Jun 14 | Sep 13 | Mar 10 | Jun 09 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | $321.68M | $313.58M | $266.03M | $373.28M | $234.77M | $295.88M | $234.79M | $250.94M | $251.77M | $234.53M | $213.26M | $218.69M | $245.56M | $249.69M | $243.38M | $240.87M | $245.68M |
| Avg Forecast | $373.35M | $330.59M | $230.11M | $209.19M | $156.21M | $223.74M | $239.29M | $236.18M | $236.18M | $224.58M | $224.56M | $229.31M | $156.33M | $59.25M | $22.24M | $177.90M | $194.77M | $269.71M | $190.00M | $22.42M |
| High Forecast | $373.35M | $330.59M | $276.14M | $251.03M | $187.45M | $268.49M | $287.15M | $236.18M | $236.18M | $224.58M | $224.56M | $229.31M | $187.60M | $71.10M | $26.69M | $213.48M | $233.72M | $323.66M | $228.00M | $26.90M |
| Low Forecast | $373.35M | $330.59M | $184.09M | $167.36M | $124.97M | $178.99M | $191.43M | $236.18M | $236.18M | $224.58M | $224.56M | $229.31M | $125.07M | $47.40M | $17.79M | $142.32M | $155.81M | $215.77M | $152.00M | $17.93M |
| # Analysts | 9 | 9 | 18 | 15 | 18 | 15 | 12 | 9 | 5 | 5 | 5 | 5 | 12 | 10 | 13 | 10 | 16 | 12 | 15 | 9 |
| Surprise % | - | - | - | 1.54% | 2.01% | 1.19% | 1.56% | 0.99% | 1.25% | 1.05% | 1.12% | 1.10% | 1.50% | 3.60% | 9.83% | 1.38% | 1.28% | 0.90% | 1.27% | 10.96% |
Oppenheimer's average Quarter revenue forecast for Mar 24 based on 18 analysts is $230.11M, with a low forecast of $184.09M, and a high forecast of $276.14M. OPY's average Quarter revenue forecast represents a -28.46% decrease compared to the company's last Quarter revenue of $321.68M (Mar 23).
Oppenheimer EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Jun 14 | Sep 13 | Mar 10 | Jun 09 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 18 | 15 | 18 | 15 | 12 | 9 | 5 | 5 | 5 | 5 | 12 | 10 | 13 | 10 | 16 | 12 | 15 | 9 |
| EBITDA | - | - | - | $32.19M | $40.96M | $25.29M | $63.20M | $25.04M | $51.06M | $26.25M | $45.37M | $30.75M | $20.13M | $254.00K | $-531.00K | $15.38M | $7.03M | $16.45M | $25.82M | $22.56M |
| Avg Forecast | $46.57M | $41.23M | $16.29M | $14.81M | $15.60M | $15.84M | $16.94M | $15.40M | $29.46M | $28.01M | $28.01M | $14.00M | $11.07M | $1.28M | $-3.66M | $10.26M | $5.04M | $18.05M | $19.49M | $2.80M |
| High Forecast | $46.57M | $41.23M | $19.55M | $17.77M | $18.72M | $19.01M | $20.33M | $18.48M | $29.46M | $28.01M | $28.01M | $16.80M | $13.28M | $1.54M | $-2.93M | $12.31M | $6.05M | $21.66M | $23.39M | $3.36M |
| Low Forecast | $46.57M | $41.23M | $13.03M | $11.85M | $12.48M | $12.67M | $13.55M | $12.32M | $29.46M | $28.01M | $28.01M | $11.20M | $8.86M | $1.02M | $-4.40M | $8.20M | $4.04M | $14.44M | $15.59M | $2.24M |
| Surprise % | - | - | - | 2.17% | 2.63% | 1.60% | 3.73% | 1.63% | 1.73% | 0.94% | 1.62% | 2.20% | 1.82% | 0.20% | 0.14% | 1.50% | 1.39% | 0.91% | 1.33% | 8.07% |
18 analysts predict OPY's average Quarter EBITDA for Mar 24 to be $16.29M, with a high of $19.55M and a low of $13.03M. This is -49.39% lower than Oppenheimer's previous annual EBITDA (Mar 23) of $32.19M.
Oppenheimer Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Jun 14 | Sep 13 | Mar 10 | Jun 09 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 18 | 15 | 18 | 15 | 12 | 9 | 5 | 5 | 5 | 5 | 12 | 10 | 13 | 10 | 16 | 12 | 15 | 9 |
| Net Income | - | - | - | $14.62M | $22.41M | $9.29M | $38.66M | $7.82M | $25.43M | $3.95M | $12.38M | $11.19M | $6.71M | $-4.85M | $-3.85M | $5.72M | $-1.55M | $5.24M | $9.17M | $7.13M |
| Avg Forecast | $17.38M | $14.92M | $5.43M | $4.93M | $11.93M | $5.28M | $5.64M | $5.13M | $8.89M | $7.00M | $5.89M | $4.67M | $3.69M | $-24.43M | $-26.54M | $3.81M | $-1.12M | $5.75M | $6.92M | $82.14M |
| High Forecast | $17.38M | $14.92M | $6.51M | $5.92M | $14.32M | $6.33M | $6.77M | $6.16M | $8.89M | $7.00M | $5.89M | $5.60M | $4.43M | $-19.54M | $-21.24M | $4.58M | $-892.55K | $6.90M | $8.30M | $98.57M |
| Low Forecast | $17.38M | $14.92M | $4.34M | $3.95M | $9.55M | $4.22M | $4.52M | $4.11M | $8.89M | $7.00M | $5.89M | $3.73M | $2.95M | $-29.31M | $-31.85M | $3.05M | $-1.34M | $4.60M | $5.54M | $65.71M |
| Surprise % | - | - | - | 2.96% | 1.88% | 1.76% | 6.85% | 1.52% | 2.86% | 0.56% | 2.10% | 2.40% | 1.82% | 0.20% | 0.14% | 1.50% | 1.39% | 0.91% | 1.33% | 0.09% |
Oppenheimer's average Quarter net income forecast for Mar 24 is $5.43M, with a range of $4.34M to $6.51M. OPY's average Quarter net income forecast represents a -62.86% decrease compared to the company's last Quarter net income of $14.62M (Mar 23).
Oppenheimer SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Jun 14 | Sep 13 | Mar 10 | Jun 09 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 18 | 15 | 18 | 15 | 12 | 9 | 5 | 5 | 5 | 5 | 12 | 10 | 13 | 10 | 16 | 12 | 15 | 9 |
| SG&A | - | - | - | $38.34M | $36.69M | $36.27M | $35.79M | $35.97M | $35.47M | $36.88M | $36.07M | $35.36M | $34.12M | $32.98M | $32.76M | $32.95M | $33.44M | $33.40M | $181.18M | $189.17M |
| Avg Forecast | $86.46M | $40.82M | $27.62M | $25.11M | $18.88M | $26.85M | $28.72M | $26.11M | $29.16M | $27.73M | $27.73M | $23.74M | $18.76M | $7.32M | $2.75M | $21.96M | $24.01M | $36.66M | $136.74M | $2.77M |
| High Forecast | $86.46M | $40.82M | $33.14M | $30.13M | $22.66M | $32.22M | $34.46M | $31.33M | $29.16M | $27.73M | $27.73M | $28.48M | $22.52M | $8.78M | $3.30M | $26.36M | $28.81M | $44.00M | $164.09M | $3.32M |
| Low Forecast | $86.46M | $40.82M | $22.10M | $20.09M | $15.10M | $21.48M | $22.98M | $20.89M | $29.16M | $27.73M | $27.73M | $18.99M | $15.01M | $5.85M | $2.20M | $17.57M | $19.21M | $29.33M | $109.39M | $2.21M |
| Surprise % | - | - | - | 1.53% | 1.94% | 1.35% | 1.25% | 1.38% | 1.22% | 1.33% | 1.30% | 1.49% | 1.82% | 4.51% | 11.93% | 1.50% | 1.39% | 0.91% | 1.33% | 68.34% |
Oppenheimer's average Quarter SG&A projection for Mar 24 is $27.62M, based on 18 Wall Street analysts, with a range of $22.10M to $33.14M. The forecast indicates a -27.96% fall compared to OPY last annual SG&A of $38.34M (Mar 23).
Oppenheimer EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Jun 14 | Sep 13 | Mar 10 | Jun 09 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 18 | 15 | 18 | 15 | 12 | 9 | 5 | 5 | 5 | 5 | 12 | 10 | 13 | 10 | 16 | 12 | 15 | 9 |
| EPS | - | - | - | $1.32 | $2.04 | $0.75 | $3.07 | $0.61 | $1.99 | $0.31 | $0.95 | $0.86 | $0.51 | $-0.36 | $-0.29 | $0.42 | $-0.11 | $0.38 | $0.69 | $0.55 |
| Avg Forecast | $1.54 | $1.34 | $1.58 | $1.43 | $1.95 | $1.43 | $0.28 | $0.80 | $0.80 | $0.63 | $0.53 | $0.54 | $0.18 | $0.50 | $-0.21 | $0.20 | $0.28 | $0.45 | $0.40 | $-0.58 |
| High Forecast | $1.54 | $1.34 | $1.58 | $1.43 | $1.95 | $1.43 | $0.33 | $0.80 | $0.80 | $0.63 | $0.53 | $0.54 | $0.21 | $0.60 | $-0.17 | $0.24 | $0.34 | $0.54 | $0.48 | $-0.46 |
| Low Forecast | $1.54 | $1.34 | $1.58 | $1.43 | $1.95 | $1.43 | $0.22 | $0.80 | $0.80 | $0.63 | $0.53 | $0.54 | $0.14 | $0.40 | $-0.25 | $0.16 | $0.22 | $0.36 | $0.32 | $-0.69 |
| Surprise % | - | - | - | 0.92% | 1.04% | 0.53% | 10.96% | 0.76% | 2.49% | 0.49% | 1.79% | 1.59% | 2.83% | -0.72% | 1.38% | 2.10% | -0.39% | 0.84% | 1.72% | -0.95% |
According to 18 Wall Street analysts, Oppenheimer's projected average Quarter EPS for Mar 24 is $1.58, with a low estimate of $1.58 and a high estimate of $1.58. This represents a 19.43% increase compared to OPY previous annual EPS of $1.32 (Mar 23).
Oppenheimer Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| OPY | Oppenheimer | $61.47 | $90.00 | 46.41% | Buy |
| NMR | Nomura | $6.05 | $5.79 | -4.30% | - |
| LAZ | Lazard | $57.12 | $53.25 | -6.78% | Buy |
| SF | Stifel Financial | $115.01 | $101.60 | -11.66% | Buy |
| HLI | Houlihan Lokey | $188.66 | $119.50 | -36.66% | Hold |
| MC | Moelis & Company | $74.64 | $47.00 | -37.03% | Buy |
| PWP | Perella Weinberg Partners | $25.77 | $15.50 | -39.85% | Buy |
| EVR | Evercore | $309.53 | $180.75 | -41.61% | Buy |
| PJT | PJT Partners | $160.81 | $79.50 | -50.56% | Buy |
| PIPR | Piper Sandler Companies | $340.34 | $162.33 | -52.30% | Buy |